Ledger.Open graph →
SEC Form D · filed May 3, 2016

Symbiomix Therapeutics, LLC

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWARK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Taylor J. Lauber · New York, NYDirectorClive J. Harris · Grand Cayman, Cayman IslandsDirectorKaren Dawes · Palm Beach Gardens, FLDirectorDavid Crisalli · Paradise Valley, AZDirectorRishi Gupta · Cambridge, MADirectorJoseph Amprey · Washington, Washington, D.C.ExecKaren Dawes · Newark, NJDirectorBen Auspitz · DURHAM, NCDirectorRobert Jacks · Newark, NJExecMichael S. Weiss · New York, NYDirectorDaniel T. Thomas · Bethesda, MDExecChristopher J. Kenny · Chicago, ILExecJoseph Amprey · Newark, NJExecKlaus Veitinger · Newark, NJDirectorThomas Beck · Newark, NJDirectorBen Auspitz · Bozeman, MTDirectorSusan E. Hodgkinson · New York, NYDirectorJ.D. T. Murphy · Bethesda, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗